Efficacy and safety of chimeric antigen receptor-T cells in the treatment of B cell lymphoma: a systematic review and meta-analysis

BACKGROUND: Conventional treatment has limited efficacy in relapsed/refractory B-cell lymphoma. Since chimeric antigen receptor T-cell (CAR-T) technology has shown high safety and results in high remission rates, we investigated its efficacy and safety in B-cell lymphoma treatment and analyzed poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Xiao-Hong, Zhang, Xi-You, Dong, Qian-Qian, Chen, Feng, Yang, Shou-Bo, Li, Wen-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Meta Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028209/
https://www.ncbi.nlm.nih.gov/pubmed/31923107
http://dx.doi.org/10.1097/CM9.0000000000000568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028209/
https://www.ncbi.nlm.nih.gov/pubmed/31923107
http://dx.doi.org/10.1097/CM9.0000000000000568

Ejemplares similares